Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1991 Dec;64(6):985–989. doi: 10.1038/bjc.1991.451

The EUROSCAN Study. EUROSCAN Steering Committee.

N de Vries, N van Zandwijk, U Pastorino
PMCID: PMC1977868  PMID: 1764390

Full text

PDF
985

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bendich A., Langseth L. Safety of vitamin A. Am J Clin Nutr. 1989 Feb;49(2):358–371. doi: 10.1093/ajcn/49.2.358. [DOI] [PubMed] [Google Scholar]
  2. Bichler E., Daxenbichler G. Retinoic acid-binding protein in human squamous cell carcinomas of the ORL region. Cancer. 1982 Feb 15;49(4):619–622. doi: 10.1002/1097-0142(19820215)49:4<619::aid-cncr2820490402>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  3. Byers T. Diet and cancer. Any progress in the interim? Cancer. 1988 Oct 15;62(8 Suppl):1713–1724. doi: 10.1002/1097-0142(19881015)62:1+<1713::aid-cncr2820621309>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  4. Colditz G. A., Stampfer M. J., Willett W. C. Diet and lung cancer. A review of the epidemiologic evidence in humans. Arch Intern Med. 1987 Jan;147(1):157–160. doi: 10.1001/archinte.147.1.157. [DOI] [PubMed] [Google Scholar]
  5. De Flora S., Astengo M., Serra D., Bennicelli C. Inhibition of urethan-induced lung tumors in mice by dietary N-acetylcysteine. Cancer Lett. 1986 Sep;32(3):235–241. doi: 10.1016/0304-3835(86)90175-8. [DOI] [PubMed] [Google Scholar]
  6. De Flora S., Bennicelli C., Camoirano A., Serra D., Romano M., Rossi G. A., Morelli A., De Flora A. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds. Carcinogenesis. 1985 Dec;6(12):1735–1745. doi: 10.1093/carcin/6.12.1735. [DOI] [PubMed] [Google Scholar]
  7. De Flora S., Bennicelli C., Zanacchi P., Camoirano A., Morelli A., De Flora A. In vitro effects of N-acetylcysteine on the mutagenicity of direct-acting compounds and procarcinogens. Carcinogenesis. 1984 Apr;5(4):505–510. doi: 10.1093/carcin/5.4.505. [DOI] [PubMed] [Google Scholar]
  8. De Flora S. Detoxification of genotoxic compounds as a threshold mechanism limiting their carcinogenicity. Toxicol Pathol. 1984;12(4):337–343. doi: 10.1177/019262338401200406. [DOI] [PubMed] [Google Scholar]
  9. Fex G., Wahlberg P., Biörklund A., Wennerberg J., Willén R. Studies of cellular retinol-binding protein (CRBP) in squamous-cell carcinomas of the head and neck region. Int J Cancer. 1986 Feb 15;37(2):217–221. doi: 10.1002/ijc.2910370208. [DOI] [PubMed] [Google Scholar]
  10. Friedman G. D., Blaner W. S., Goodman D. S., Vogelman J. H., Brind J. L., Hoover R., Fireman B. H., Orentreich N. Serum retinol and retinol-binding protein levels do not predict subsequent lung cancer. Am J Epidemiol. 1986 May;123(5):781–789. doi: 10.1093/oxfordjournals.aje.a114307. [DOI] [PubMed] [Google Scholar]
  11. Gluckman J. L., Crissman J. D., Donegan J. O. Multicentric squamous-cell carcinoma of the upper aerodigestive tract. Head Neck Surg. 1980 Nov-Dec;3(2):90–96. doi: 10.1002/hed.2890030203. [DOI] [PubMed] [Google Scholar]
  12. Gluckman J. L., Crissman J. D. Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract. Laryngoscope. 1983 Jan;93(1):71–74. doi: 10.1288/00005537-198301000-00014. [DOI] [PubMed] [Google Scholar]
  13. Goepfert H. Are we making any progress? Arch Otolaryngol. 1984 Sep;110(9):562–563. doi: 10.1001/archotol.1984.00800350004002. [DOI] [PubMed] [Google Scholar]
  14. Hong W. K., Lippman S. M., Itri L. M., Karp D. D., Lee J. S., Byers R. M., Schantz S. P., Kramer A. M., Lotan R., Peters L. J. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990 Sep 20;323(12):795–801. doi: 10.1056/NEJM199009203231205. [DOI] [PubMed] [Google Scholar]
  15. Hordijk G. J., de Jong J. M. Synchronous and metachronous tumours in patients with head and neck cancer. J Laryngol Otol. 1983 Jul;97(7):619–621. doi: 10.1017/s002221510009469x. [DOI] [PubMed] [Google Scholar]
  16. Lippman S. M., Hong W. K. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):691–694. doi: 10.1016/0360-3016(89)90126-0. [DOI] [PubMed] [Google Scholar]
  17. Lippman S. M., Lee J. S., Lotan R., Hittelman W., Wargovich M. J., Hong W. K. Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst. 1990 Apr 4;82(7):555–560. doi: 10.1093/jnci/82.7.555. [DOI] [PubMed] [Google Scholar]
  18. Menkes M. S., Comstock G. W., Vuilleumier J. P., Helsing K. J., Rider A. A., Brookmeyer R. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med. 1986 Nov 13;315(20):1250–1254. doi: 10.1056/NEJM198611133152003. [DOI] [PubMed] [Google Scholar]
  19. Middleton B., Byers T., Marshall J., Graham S. Dietary vitamin A and cancer--a multisite case-control study. Nutr Cancer. 1986;8(2):107–116. doi: 10.1080/01635588609513883. [DOI] [PubMed] [Google Scholar]
  20. Pastorino U., Chiesa G., Infante M., Soresi E., Clerici M., Valente M., Belloni P. A., Ravasi G. Safety of high-dose vitamin A. Randomized trial on lung cancer chemoprevention. Oncology. 1991;48(2):131–137. doi: 10.1159/000226912. [DOI] [PubMed] [Google Scholar]
  21. Peto R., Doll R., Buckley J. D., Sporn M. B. Can dietary beta-carotene materially reduce human cancer rates? Nature. 1981 Mar 19;290(5803):201–208. doi: 10.1038/290201a0. [DOI] [PubMed] [Google Scholar]
  22. Prescott L. F., Illingworth R. N., Critchley J. A., Stewart M. J., Adam R. D., Proudfoot A. T. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J. 1979 Nov 3;2(6198):1097–1100. doi: 10.1136/bmj.2.6198.1097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. SILVERMAN S., Jr, RENSTRUP G., PINDBORG J. J. STUDIES IN ORAL LEUKOPLAKIAS. III. EFFECTS OF VITAMIN A COMPARING CLINICAL, HISTOPHATHOLOGIC, CYTOLOGIC, AND HEMATOLOGIC RESPONSES. Acta Odontol Scand. 1963 Jun;21:271–292. doi: 10.3109/00016356308993961. [DOI] [PubMed] [Google Scholar]
  24. Schantz S. P., Hsu T. C. Mutagen-induced chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients. Head Neck. 1989 Jul-Aug;11(4):337–342. doi: 10.1002/hed.2880110409. [DOI] [PubMed] [Google Scholar]
  25. Schantz S. P., Spitz M. R., Hsu T. C. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst. 1990 Nov 21;82(22):1773–1775. doi: 10.1093/jnci/82.22.1773. [DOI] [PubMed] [Google Scholar]
  26. Spitz M. R., Fueger J. J., Beddingfield N. A., Annegers J. F., Hsu T. C., Newell G. R., Schantz S. P. Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res. 1989 Aug 15;49(16):4626–4628. [PubMed] [Google Scholar]
  27. Tepperman B. S., Fitzpatrick P. J. Second respiratory and upper digestive tract cancers after oral cancer. Lancet. 1981 Sep 12;2(8246):547–549. doi: 10.1016/s0140-6736(81)90938-7. [DOI] [PubMed] [Google Scholar]
  28. Tuyns A. J. Epidemiology of alcohol and cancer. Cancer Res. 1979 Jul;39(7 Pt 2):2840–2843. [PubMed] [Google Scholar]
  29. Vrabec D. P. Multiple primary malignancies of the upper aerodigestive system. Ann Otol Rhinol Laryngol. 1979 Nov-Dec;88(Pt 1):846–854. doi: 10.1177/000348947908800620. [DOI] [PubMed] [Google Scholar]
  30. WYNDER E. L., BROSS I. J., DAY E. A study of environmental factors in cancer of the larynx. Cancer. 1956 Jan-Feb;9(1):86–110. doi: 10.1002/1097-0142(195601/02)9:1<86::aid-cncr2820090108>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  31. WYNDER E. L., BROSS I. J., FELDMAN R. M. A study of the etiological factors in cancer of the mouth. Cancer. 1957 Nov-Dec;10(6):1300–1323. doi: 10.1002/1097-0142(195711/12)10:6<1300::aid-cncr2820100628>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  32. Wilpart M., Speder A., Roberfroid M. Anti-initiation activity of N-acetylcysteine in experimental colonic carcinogenesis. Cancer Lett. 1986 Jun;31(3):319–324. doi: 10.1016/0304-3835(86)90154-0. [DOI] [PubMed] [Google Scholar]
  33. Ziegler R. G., Mason T. J., Stemhagen A., Hoover R., Schoenberg J. B., Gridley G., Virgo P. W., Altman R., Fraumeni J. F., Jr Dietary carotene and vitamin A and risk of lung cancer among white men in New Jersey. J Natl Cancer Inst. 1984 Dec;73(6):1429–1435. [PubMed] [Google Scholar]
  34. de Vries N., Drexhage H. A., de Waal L. P., de Lange G., Snow G. B. Human leukocyte antigens and immunoglobulin allotypes in head and neck cancer patients with and without multiple primary tumors. Cancer. 1987 Sep 1;60(5):957–961. doi: 10.1002/1097-0142(19870901)60:5<957::aid-cncr2820600507>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  35. de Vries N., Snow G. B. Multiple primary tumours in laryngeal cancer. J Laryngol Otol. 1986 Aug;100(8):915–918. doi: 10.1017/s0022215100100313. [DOI] [PubMed] [Google Scholar]
  36. de Vries N., Snow G. B. Relationships of vitamins A and E and beta-carotene serum levels to head and neck cancer patients with and without second primary tumors. Eur Arch Otorhinolaryngol. 1990;247(6):368–370. doi: 10.1007/BF00179009. [DOI] [PubMed] [Google Scholar]
  37. de Vries N., Van der Waal I., Snow G. B. Multiple primary tumours in oral cancer. Int J Oral Maxillofac Surg. 1986 Feb;15(1):85–87. doi: 10.1016/s0300-9785(86)80015-1. [DOI] [PubMed] [Google Scholar]
  38. de Vries N., de Lange G., Drexhage H. A., Snow G. B. Immunoglobulin allotypes in head and neck cancer patients with multiple primary cancers. Acta Otolaryngol. 1987 Jul-Aug;104(1-2):187–191. doi: 10.3109/00016488709109066. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES